BioSpace News Archive

Deals

ScreenPro Announces Grant of Stock Options

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce that the Company has granted stock options (“Options”) to employees, officers and directors of the Company.

January 30, 2023
·
3 min read
Business

SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results

SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2022.

January 30, 2023
·
6 min read
Biotech Bay

Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today provided an update on the company’s development pipeline and business outlook for 2023.

January 30, 2023
·
5 min read
Business

James A. Reeves, Jr., MD, Clinical Research Leader, to Retire From Florida Cancer Specialists & Research Institute

Florida Cancer Specialists & Research Institute, LLC announces that James A. Reeves Jr, MD will retire from its Research Division, effective January 31, 2023.

January 30, 2023
·
3 min read